Skip to content

Effect of Depressin Screening and Care Program at Community Health Center

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01626703
Enrollment
86
Registered
2012-06-25
Start date
2012-06-30
Completion date
2013-03-31
Last updated
2016-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Elderly, Screening

Brief summary

Depression affect between 5% and 10% of older adults seen in the primary care setting.Late-life depression is often chronic or recurrent and is associated with substantial suffering, functional impairment, and diminished health-related quality of life.Depressed, older primary care patients are frequent users of general medical services and may have poor adherence to medical treatments.They are also at increased risk of death from suicide and medical illnesses. The aim of this study is to examine whether depression screening and health care practitioner feedback are increased depression treatment rate. Depression screening is provided 60 or more who visited community health care center with a 15-item Geriatric Depression Scale.GDS scores of 10 or more were classified depression positive. Intervention group participants received twice remind calls from primary care nurse.

Interventions

OTHERReminding call

Sponsors

National Clinical Research Coordination Center, Seoul, Korea
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 60 or more * 10 or more in GDS scor

Exclusion criteria

* severe cognitive problem

Design outcomes

Primary

MeasureTime frame
Reuptake rate12 weeks

Secondary

MeasureTime frameDescription
reduced depressive symptoms12 weeksGeriatric Depression Scale Short Form (SGDS)
changed perceived heath status12 weeksVisual Analogue Scale (VAS)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026